Eucrates Biomedical Acquisition Corp (EUCR)
NCM · SPAC · CUSIP G3141W114
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for EUCR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Special Purpose Acquisition Company (SPAC)
CUSIP
G3141W114
Market Cap
Small Cap · $134 Million
IPO
10/26/2020
Business: Eucrates Biomedical Acquisition Corp. is a blank check company incorporated in the British Virgin Islands as a business company and formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The Company intends to focus on businesses focusing on the biomedical or healthcare-related industries.
Notes: We know of no home page for this Company.

Company Contact

CEO
Parag Saxena
CFO
Gonzalo Cordova
Headquarters
250 W 55th Street, Suite 13D, New York, NY 10019
Phone
212-710-5220
SEC EDGAR Filings
View filings »
Find all related securities for EUCR »